Thoracic medical oncologist & researcher @JulesBordet & associate professor @ULB in #Brussels 🇧🇪 working in #lungcancer #neutrophils #translationalresearch #phase1 & #globalhealthhttps://bsky.app/profile/marianabrandao0.bsky.socialhttps://bsky.app/profile/marianabrandao0.bsky.social/post/3ld6vuo53i22cWhat's the Land of Tomorrow of #IO in #NSCLC? At #ESMOImmune2024 I had the honor to discuss the data on 🔴 PDC*lung01 vaccine + Pembro in 1L PD-L1 high 🔴 Inupadenant +carbo/pem after IO failure 🔴 Effectiveness & immunophenotype in orphan genomic alterations @oncoalert.bsky.social #lcsm13 Dec 2024 13:39 +0000at://did:plc:wdrywaitiypd3xrfkkmzeplh/app.bsky.feed.post/3ld6vuo53i22chttps://bsky.app/profile/marianabrandao0.bsky.social/post/3ld6jynqwxk2cExciting data at #ESMOImmumo2024 showed by George Coukos on adoptive immune cell therapies: 🔵 Nb of reactive antitumor TILs that are injected correlate with response 🔵 How to improve #TIL treatments in pts with #melanoma @oncoalert.bsky.social13 Dec 2024 10:06 +0000at://did:plc:wdrywaitiypd3xrfkkmzeplh/app.bsky.feed.post/3ld6jynqwxk2chttps://bsky.app/profile/marianabrandao0.bsky.social/post/3ld6euimmys2cHow to counteract the immunosuppressive action of #adenosine in #TNBC? @laubdh.bsky.social explains her journey from bench to bedside with the SYNERGY and NeoCheckRay trials & the intense ongoing TR to understand who're the pts who benefit from anti-CD73 🔬👏💪 @oncoalert.bsky.social #ESMOImmuno202413 Dec 2024 08:35 +0000at://did:plc:wdrywaitiypd3xrfkkmzeplh/app.bsky.feed.post/3ld6euimmys2chttps://bsky.app/profile/marianabrandao0.bsky.social/post/3lc4ducfkac2bCongratulations @mattiarediti.bsky.social & Christos Sotiriou for this extraordinary work on HER2+ breast cancer!! 💪👏👏 [contains quote post or other embedded content]29 Nov 2024 19:46 +0000at://did:plc:wdrywaitiypd3xrfkkmzeplh/app.bsky.feed.post/3lc4ducfkac2bhttps://bsky.app/profile/marianabrandao0.bsky.social/post/3lc3x7zlmc22wImpressive talk by Barbara Pistilli on #ADCs at the 18th Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice by #BSMO & #JulesBordet 🚨 🔴How ADCs are made? 🔴What mechanisms of resistance? 🔴How to improve efficacy? @oncoalert.bsky.social29 Nov 2024 16:00 +0000at://did:plc:wdrywaitiypd3xrfkkmzeplh/app.bsky.feed.post/3lc3x7zlmc22whttps://bsky.app/profile/marianabrandao0.bsky.social/post/3lbrywhzc322yDon't miss the next #ESMO Virtual Journal Club on Wed 4/Dec🔎📃 we'll discuss: #LAURA trial: Osi after CRT in #NSCLC 🫁 #RUBY trial: dostarlimab +carbo/paclitaxel in #endometrialcancer 🚨Don't forget to register! 👇 @oncoalert.bsky.social https://www.esmo.org/meeting-calendar/esmo-virtual-journal-club-december-202425 Nov 2024 17:04 +0000at://did:plc:wdrywaitiypd3xrfkkmzeplh/app.bsky.feed.post/3lbrywhzc322y